First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors (vol 42, 76, 2023)
Christopher B. Cole,Maria Pia Morelli,Massimo Fantini,Markku Miettinen,Patricia Fetsch,Cody Peer,William D. Figg,Tyler Yin,Nicole Houston,Ann McCoy,Stanley Lipkowitz,Alexandra Zimmer,Jung-min Lee,Miroslava Pavelova,Erin N. Villanueva,Kathryn Trewhitt, B. Brooke Solarz,Maria Fergusson,Sharon A. Mavroukakis,Anjum Zaki,Kwong Y. Tsang,Philip M. Arlen,Christina M. Annunziata JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH（2023）
AI 理解论文
溯源树
样例
